Use of incretin-based medications: what do current international recommendations suggest with respect to GLP-1 receptor agonists and DPP-4 inhibitors?

MLA

Stefano Del Prato, et al. Use of Incretin-Based Medications: What Do Current International Recommendations Suggest with Respect to GLP-1 Receptor Agonists and DPP-4 Inhibitors? Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....91503cbb492c33db875e0fadedae2af0&authtype=sso&custid=ns315887.

APA

Stefano Del Prato, Melanie J. Davies, & Cristina Bianchi. (2020). Use of incretin-based medications: what do current international recommendations suggest with respect to GLP-1 receptor agonists and DPP-4 inhibitors?

Chicago

Stefano Del Prato, Melanie J. Davies, and Cristina Bianchi. 2020. “Use of Incretin-Based Medications: What Do Current International Recommendations Suggest with Respect to GLP-1 Receptor Agonists and DPP-4 Inhibitors?,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....91503cbb492c33db875e0fadedae2af0&authtype=sso&custid=ns315887.